Interestingly, several disease-related pathways were significantly enriched, including those associated with neurodegeneration (e.g., Parkinson’s, Huntington’s, and Alzheimer’s diseases), diabetes neuropathy, and immune-related signaling, such as the HIF-1 and glucagon signaling pathways. The gene discussed is GCG; the disease is early-onset autosomal dominant Alzheimer disease.